| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/26/2005 | EP1499349A2 Recombinant hybrid allergen constructs with reduced allergenicity that retain immunogenicity of the natural allergen |
| 01/26/2005 | EP1438331A4 A novel modulator of non-genonic activity of nuclear receptors (mnar) and uses thereof |
| 01/26/2005 | EP1383889A4 Modified organs and cells for xenotransplantation |
| 01/26/2005 | EP1127133B1 Polypeptide mediating cell permeability |
| 01/26/2005 | EP1092021B1 Npy-y7 receptor gene |
| 01/26/2005 | EP1021556B9 Assay using marked microbial host cell strains |
| 01/26/2005 | EP1015612B1 Process for preparing recombinant proteins using highly efficient expression vector from saccharomyces cerevisiae |
| 01/26/2005 | EP0886651B1 Persephin and related growth factors |
| 01/26/2005 | EP0793717B1 Oral immunization with transgenic plants |
| 01/26/2005 | EP0791063B1 Carrier protein having an adjuvant effect, immunogenic complex containing same, preparation method therefor, nucleotide sequence and vaccine |
| 01/26/2005 | EP0750665B1 cDNAs ENCODING MINOR AMPULLATE SPIDER SILK PROTEINS |
| 01/26/2005 | EP0652953B1 Morphogenic protein soluble complex and composition thereof |
| 01/26/2005 | EP0579758B1 Parathyroid hormone receptor and dna encoding same |
| 01/26/2005 | EP0451244B9 Subtilisin mutants |
| 01/26/2005 | CN1571836A Human antibodies specific for interleukin 15 (IL-15) |
| 01/26/2005 | CN1571834A Cell therapy method for the treatment of tumors |
| 01/26/2005 | CN1571797A Anti-hla-dr antibody |
| 01/26/2005 | CN1571675A Treatment and diagnosis of insulin-resistant states |
| 01/26/2005 | CN1570130A Cyclosporins A fermentation production method |
| 01/26/2005 | CN1570129A Egg small peptide preparing process |
| 01/26/2005 | CN1570128A Production of functional polypeptides originating from silk protein and use thereof |
| 01/26/2005 | CN1570127A High F value oligopeptide production method by corn protein enzymolysis |
| 01/26/2005 | CN1570119A Recombinant human stem cell factor prokaryote expression vector, engineering bacteria and its preparation method |
| 01/26/2005 | CN1570102A Wheat yellow dwarf disease candidate resistance gene and its coded protein and uses |
| 01/26/2005 | CN1570100A Nerval incretion specific protein analog, its coding sequence, making method and uses |
| 01/26/2005 | CN1569898A Recombinant human antibody against HBsAg and its preparation method |
| 01/26/2005 | CN1569035A Manufacturing method of biological protein calcium with metal sulfur protein |
| 01/25/2005 | US6846920 Comprises nucleotide sequences coding eosinophil protease (EOS) for preparing laundry detergents, stain-removing solutions, skin care products and treating blood and respiratory system disorders |
| 01/25/2005 | US6846912 Monoclonal antibody specific for leukocyte antigen related (LAR) phosphatase for diagnosis and treatment of thyroid cancer insulin resistance and arteriosclerosis |
| 01/25/2005 | US6846910 Dimeric proteins for use in the treatment of cancer |
| 01/25/2005 | US6846908 DCR-5 bone affecting ligand |
| 01/25/2005 | US6846906 Modified proteins of the TGF-β superfamily, including morphogenic proteins |
| 01/25/2005 | US6846667 Virulence genes and proteins, and their use |
| 01/25/2005 | US6846650 Nucleotide sequences coding polypeptide for use in the imaging, diagnosis, treatment classification and prevention of lung cancer |
| 01/25/2005 | US6846649 Recombinant human mannan-binding lectin |
| 01/25/2005 | US6846634 Method to screen phage display libraries with different ligands |
| 01/25/2005 | CA2308292C Method of dna shuffling |
| 01/25/2005 | CA2123224C Murine monoclonal antibody (5c8) recognizes a human glycoprotein on the surface of t-lymphocytes |
| 01/20/2005 | WO2005005638A2 High affinity fusion proteins (rc-scfv-fc or scfv-scfv-fc) binding cytokines, particularly il-6 & il-18 |
| 01/20/2005 | WO2005005616A2 Compositions and methods for stable isotope labelling of biological compounds |
| 01/20/2005 | WO2005005598A2 B. anthracis luxs and furanone inhibition of a1-2 quorum sensing |
| 01/20/2005 | WO2005004793A2 Compositions and methods for treating coagulation related disorders |
| 01/20/2005 | WO2004015057A3 Mucin-immunoglobulin fusion proteins |
| 01/20/2005 | WO2003066881A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 01/20/2005 | WO2003057155A3 Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor |
| 01/20/2005 | WO2003035848A9 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer |
| 01/20/2005 | WO2002050289A8 Methods for the production of multimeric proteins, and related compositions |
| 01/20/2005 | US20050015830 transforming or transfecting using nucleotide sequence encoding fusion protein, signal peptide and polypeptide to help in binding to cell wall; |
| 01/20/2005 | US20050015822 Mass 1 gene, a target for anticonvulsant drug development |
| 01/20/2005 | US20050015820 Using transgenic mouse tissue as model for monitoring agents that affect appetite, energy expenditure and caloric and food intake; dietetics and weight gain |
| 01/20/2005 | US20050014933 Process for renaturation of recombinant, disulfide containing proteins at high protein concentrations in the presence of amines |
| 01/20/2005 | US20050014718 Tumor specific oligosaccharide sequences and use thereof |
| 01/20/2005 | US20050014695 Uses of a chemokine receptor able to bind to MCP-1, MIP-1 alpha and/or rantes |
| 01/20/2005 | US20050014687 Nucleoc acid sequences coding polypeptides; binding to antibodies; diagnosis, therapy of diseases such as cancer |
| 01/20/2005 | US20050014260 Fusion protein delivery system and uses thereof |
| 01/20/2005 | US20050014251 Production fo eukaryotic proteins and nucleic acid molecules in c. elegans |
| 01/20/2005 | US20050014242 Expression vector comprising nuclelotide sequences coding seriene protease for use as therapeutic protein in treatment of inflammatory, reproductive, epidermal and neurological tissue disorders |
| 01/20/2005 | US20050014230 Generating immunoglobulin specific for human lymphadenopathy viral glycoprotein 120 for use in prevention and treatment of viral diseases; immunotherapy |
| 01/20/2005 | US20050014229 Using transgenic animal to prepare osteoclastogenesis inhibitory factor (OCIF) for use in treatment of osteoporosis |
| 01/20/2005 | US20050014228 Cytokine receptor protein for use in identifying modulators which prevent hepatitis viral replication and infection; viricides |
| 01/20/2005 | US20050014223 Renilla GFP mutants with increased fluorescent intensity and spectral shift |
| 01/20/2005 | US20050014222 Phosphatases which activate map kinase pathways |
| 01/20/2005 | US20050014203 Liquid tissue preparation from histopathologically processed biological samples, tissues and cells |
| 01/20/2005 | US20050014187 Novel polypeptide hormone phosphatonin |
| 01/20/2005 | US20050013901 Distillers solubles as a constituent for nisin and lactic acid production from dairy cheese by products |
| 01/20/2005 | US20050013864 In situ administering; mixture of bone morphogenic protein and ethylene oxide-propylene oxide copolymer |
| 01/20/2005 | US20050013827 Novel molecules of the herpesvirus-entry-mediator-related protein family and uses thereof |
| 01/20/2005 | CA2532038A1 Compositions and methods for stable isotope labelling of biological compounds |
| 01/20/2005 | CA2530980A1 Tissue factor-specific antibodies for preventing or treating acute lung injury or acute respiratory distress syndrome |
| 01/19/2005 | EP1498491A1 METHOD OF ENHANCING ACTIVITY OF ANTIBODY COMPOSITION OF BINDING TO Fc GAMMA RECEPTOR IIIa |
| 01/19/2005 | EP1498490A1 Process for producing antibody composition |
| 01/19/2005 | EP1498485A1 Cells with modified genome |
| 01/19/2005 | EP1498481A1 Mutated subtilisin genes |
| 01/19/2005 | EP1498428A1 Antibodies for detecting ecstasy-class analytes |
| 01/19/2005 | EP1498427A1 Immunoglobulins devoid of light chains |
| 01/19/2005 | EP1498426A1 Preparation of fully human antibodies |
| 01/19/2005 | EP1497658A2 Protein involved in cancer |
| 01/19/2005 | EP1497656A2 Diagnosis of carcinoma using raig1 polypeptides |
| 01/19/2005 | EP1497653A2 Compositions, methods and kits for immunochemical determination of mannan-binding lectin (mbl) |
| 01/19/2005 | EP1497634A2 Protein knobs |
| 01/19/2005 | EP1497469A2 Assay for evaluation of activity of compounds against hcv using a novel detection system in the hcv replicon |
| 01/19/2005 | EP1497467A2 Oligonucleotides from sequences coding for the surface component of ptlv envelope proteins and uses thereof |
| 01/19/2005 | EP1497445A2 Antibodies that specifically bind to gmad |
| 01/19/2005 | EP1497444A2 Methods for increasing polypeptide production |
| 01/19/2005 | EP1497431A2 Improved bacillus host cell |
| 01/19/2005 | EP1497430A2 Improved bacillus host cell |
| 01/19/2005 | EP1497429A2 Improved bacillus host cell |
| 01/19/2005 | EP1497427A2 Helicokinin-receptor from insects |
| 01/19/2005 | EP1497418A2 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 01/19/2005 | EP1497415A2 Cytokine receptor |
| 01/19/2005 | EP1497413A1 Methods for producing immortalised antibodies-secreting cells |
| 01/19/2005 | EP1497334A2 Protein stabilisation using chaperone proteins |
| 01/19/2005 | EP1497319A2 Cell adhesion and extracellular matrix proteins |
| 01/19/2005 | EP1497315A2 Nucleic acid-associated proteins |
| 01/19/2005 | EP1497313A2 Immunogenic peptide composition for the prevention and treatment of alzheimer's disease |
| 01/19/2005 | EP1497307A2 Recombinant p.falciparum merozoite protein-1 42 vaccine |
| 01/19/2005 | EP1496945A1 Mycoplasma polypeptides |
| 01/19/2005 | EP1496834A2 High affinity integrin polypeptides and uses thereof |
| 01/19/2005 | EP1496743A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/19/2005 | EP1496737A2 .ce1, a regulator of cold induced transcriptome and freezing tolerance in plants |